TRO and breast cancer: Mehta et al. took this approach into mouse models and found that the combination of LG10068, an RXRα-specific ligand, and TRO completely inhibited development of mammary tumours at micromolar concentrations in a DMBA-induced breast tumourigenesis model [17].